phuttaphat tipsana/iStock via Getty Images Thesis overview Evaxion (EVAX) aspires to use artificial intelligence (AI) to design vaccines for cancer immunotherapy, as well as for infectious diseases. EVAX claims being more advanced than competition because it has been constantly developing and improving its models for 15 years. Additionally, EVAX has in-house capability to validate novel…
Going into the future of Bitcoin adoption and development there is one issue of software interacting that is coming to the forefront of roadblocks developers must deal with: compatibility. As applications and protocols in this space become more complex and featureful in order to meet the needs of actual users and use cases, this presents…
hh5800/iStock via Getty Images Deals and Financings Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma (OTCPK:ALPMF, TSE: 4503) to develop a novel bispecific macrophage engager, ES019, along with an unspecified program (see story). Initially, Elpiscience will receive up to $37 million, including an upfront payment and license option fees. Astellas…
gustavofrazao A Quick Take On Vinci Partners Investments Vinci Partners Investments (NASDAQ:VINP) reported its Q3 2023 financial results on November 8, 2023, reporting year-over-year fee-related revenue growth of 4%. The firm provides investors with access to various investment products in Brazil. I previously wrote about VINP with a Buy outlook on its growth potential from…
With the number of people involved in crypto in South Korea, SK Telecom aims to expand the accessibility of its wallet to attract more users and improve adoption in the country. SK Telecom, one of South Korea’s leading telecommunications giants, has announced its partnership with Aptos Network, a layer 1 blockchain protocol, and Atomrigs Lab…